What advantages does reteplase have over alteplase for treating acute myocardial infarction?
Reteplase has several advantages over alteplase for treating acute myocardial infarction. In comparison to alteplase, reteplase is associated with fewer bleeding complications, a shorter half-life, improved myocardial perfusion, and a decreased risk of reocclusion of the coronary artery. Additionally, reteplase has been shown to reduce mortality at 30 days when compared to alteplase. Thus, reteplase may be a more effective and safer treatment option for patients with acute myocardial infarction.